Timing clarification: Emerson reports after the market closes today, Tuesday, August 4, 2026, not tomorrow. The earnings call begins at 4:30 p.m. ET. (ir.emerson.com)
Emerson enters fiscal Q3 with a favorable demand backdrop and unusually good revenue visibility, but also with a fairly high bar. The company guided the quarter to approximately 5% underlying sales growth, 28% adjusted segment EBITA margin, and $1.65–$1.70 of adjusted EPS. Current consensus is roughly $1.67–$1.68 of adjusted EPS and $4.79–$4.80 billion of revenue, almost exactly matching management’s framework. (ir.emerson.com)
The quarter’s headline beat or miss may therefore be less important than:
The shares closed at $154.88 on August 3, up about 17% year to date and roughly 12% since the Q2 report. At approximately 24 times fiscal 2026 consensus EPS, the valuation appears to anticipate solid execution. A routine in-line quarter may not be enough for meaningful upside; investors will probably want a constructive fiscal Q4 setup and confidence in fiscal 2027.
| Metric | Fiscal Q3 expectation |
|---|---|
| Revenue consensus | ~$4.79–$4.80B |
| Revenue growth | ~5.3% YoY |
| Management underlying sales guide | ~5% |
| Adjusted EPS consensus | ~$1.67–$1.68 |
| Management adjusted EPS guide | $1.65–$1.70 |
| Prior-year adjusted EPS | $1.52 |
| Adjusted segment EBITA margin guide | ~28% |
| Full-year adjusted EPS guide | $6.45–$6.55 |
| Full-year underlying sales guide | ~3% |
| Full-year free cash flow guide | $3.5–$3.6B |
Consensus revenue implies about 5.3% year-over-year growth, broadly consistent with management’s 5.5% reported-growth and 5% underlying-growth forecasts. Consensus EPS also sits near the midpoint of guidance, leaving limited scope for an “easy” expectations beat. (stage.zacks.com)
Fiscal Q2 underlying sales increased only 0.5%, affected by the Middle East disruption and a software contract-renewal comparison. However, underlying orders grew 5%, backlog reached $8.2 billion, up 9%, and book-to-bill was 1.07.
Management consequently forecast a sharp Q3 acceleration to approximately 5% underlying growth. That forecast was supported by backlog phasing rather than a need for a sudden improvement in short-cycle demand.
A result near the revenue guide should therefore be achievable. The more important question is whether orders replenish the backlog fast enough to support fiscal Q4 and early fiscal 2027.
Positive signal: Underlying orders of at least 5%, book-to-bill around or above 1.0, and continued backlog growth.
Warning signal: Sales meet expectations through backlog conversion, but orders slow materially—especially in Intelligent Devices.
Management projected approximately 8% underlying growth for Software & Systems in Q3, including:
Test & Measurement grew 12% underlying in Q2, led by semiconductor and aerospace-and-defense applications. Management said double-digit growth should be sustainable over the next several quarters. Control Systems also benefits from power investment through Ovation and from life-sciences projects through DeltaV.
The key concern is mix. Backlog-driven project revenue can carry lower margins than software renewals and higher-margin product sales. Thus, strong segment growth accompanied by disappointing segment margin would be less impressive than the headline revenue suggests.
Power has become one of Emerson’s strongest growth engines:
The demand spans generation, plant modernization, transmission and distribution, and behind-the-meter power for data centers. This gives Emerson broader exposure than a simple data-center equipment trade.
Investors should listen for:
Power does not need to accelerate every quarter, but management needs to show that recent order strength is translating into multiyear revenue visibility.
In Q2, the Middle East conflict reduced consolidated underlying sales growth by approximately one percentage point. Emerson lowered full-year expectations to account for roughly $150 million of disruption, including approximately $50 million in Q2 and another $100 million anticipated in the second half.
The Q3 guidance assumed a gradual operational recovery and that the conflict remained geographically contained. At the last update:
The quarter will test whether this recovery proceeded according to plan. An improvement in service, MRO, logistics, and project execution would support the current full-year outlook. Renewed disruption could pressure Intelligent Devices revenue, although the regional business carries below-average margins, partly limiting the earnings effect.
The rebuild opportunity is upside, but investors should avoid treating it as immediate Q3 revenue. Management previously characterized it as a multiquarter opportunity.
Management guided adjusted segment EBITA margin to approximately 28%, versus 27.6% in Q2 and 27.1% in the prior-year Q3.
Several factors support improvement:
Potential offsets include:
A 28% result would confirm that Emerson can protect profitability despite uneven regional demand. A material shortfall would raise questions about the company’s longer-term target of 30% adjusted segment EBITA margin by fiscal 2028. Emerson’s 2028 framework also calls for $21 billion of revenue, $8 of adjusted EPS, and a 20% free-cash-flow margin. (ir.emerson.com)
Current fiscal 2026 guidance calls for:
Wall Street’s fiscal-year EPS consensus is approximately $6.49, near the midpoint of company guidance. The market is therefore not pricing a major earnings reset, but it is also leaving management room for a modest raise if Q3 lands near the high end and the Middle East recovery remains on track. (stage.zacks.com)
Assuming Q3 adjusted EPS falls within the guided range, existing full-year guidance implies approximately $1.75–$1.90 of Q4 adjusted EPS. That is a meaningful sequential step-up. Investors should focus on whether management explicitly supports that implied finish.
A raise driven by:
A raise driven mainly by foreign exchange, taxes, or share count would be less compelling.
Management expects China to decline at a mid-single-digit rate for the year, primarily because of weak chemical-industry spending, while Europe remains soft. An unchanged outlook is manageable because North America and India have been compensating.
A further China downgrade would matter most if it spreads beyond chemicals into broader automation demand.
First-half free cash flow was held back by tax timing, working-capital investment, and interest expense. Management retained its $3.5–$3.6 billion annual target, implying a heavily second-half-weighted year and an 18.6%–19.2% free-cash-flow margin on current revenue consensus.
Investors should look for evidence that inventory and receivables are converting as backlog ships. Another working-capital build would make the full-year target more demanding.
Emerson’s software is specialized, mission-critical industrial software rather than general-purpose enterprise software. Management continues to target at least 10% ACV growth and argues that AI should improve the value of its portfolio rather than displace it.
Near-term revenue from newer AI products is still limited. The investable signal is therefore not “AI revenue” but software ACV, renewal rates, cross-selling, and evidence that Emerson’s integrated software architecture is winning larger deployments.
This would reinforce the thesis that Emerson has become a structurally faster-growing, higher-margin automation company.
This would be operationally solid, though the stock reaction could be muted given the recent rally and elevated valuation.
The most concerning outcome would be a Q3 revenue miss accompanied by weaker orders, since that would challenge both current execution and the fiscal 2027 setup.
This is primarily an orders, guidance, and quality-of-growth quarter, not just an EPS event.
Emerson should be able to deliver close to its Q3 financial targets based on backlog, pricing, and strength in power and Test & Measurement. The harder test is proving that these drivers remain durable enough to support a strong fiscal Q4 and the company’s 2028 value-creation framework.
The cleanest positive report would combine:
With the shares already trading near 24 times current-year earnings, the market is likely to reward forward visibility more than a small quarterly EPS beat.